Gruppo di Studio Ginecologia Prodotti – AIRO

Gruppo di Studio Ginecologia Prodotti

Contouring of emerging organs-at-risk (OARS) of the female pelvis and interobserver variability: A study by the Italian association of radiotherapy and clinical oncology (AIRO)

Visualizza Documento …

Definitive chemoradiation in vulvar squamous cell carcinoma: outcome and toxicity from an observational multicenter Italian study on vulvar cancer (OLDLADY 1.1)

Visualizza Documento …

“Survey sulle Conoscenze e Atteggiamenti relativi all’Utilizzo della Radioterapia Stereotassica nella Gestione del Tumore ovarico oligometastatico/persistente/ricorrente (MPR-OC) in Trattamento con PARP-Inibitori” – deadline 15-07-2023

Lettera di invito alla compilazione Link per la Compilazione della Survey …

EFFICACY AND SAFETY OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN OLIGOMETASTATIC UTERINE CANCER (MITO-RT2/RAD STUDY): A LARGE, REAL-WORLD STUDY IN COLLABORATION WITH AIRO GYN, MITO and MaNGO Groups

Visualizza Documento …

Vaginal Toxicity Management

Visualizza Documento …

Observational multicenter Italian study on vulvar cancer adjuvant radiotherapy (OLDLADY 1.2): a cooperation among AIRO Gyn, MITO and MaNGO groups

Visualizza Documento …

Postoperative treatment of intermediate-risk early stage cervical cancer: results of a survey from the Gynecology Study Group in the AIRO Gyn and MITO Groups

Visualizza Documento …

Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/ RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups

Visualizza Documento …

Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/ persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/ RAD)

Visualizza Documento …

Brachytherapy or external beam radiotherapy as a boost in locally advanced cervical cancer: a Gynaecology Study Group in the Italian Association of Radiation and Clinical Oncology (AIRO) review

Visualizza Documento …

Cervical cancer patterns of care in Italy_ A radiation oncology survey of MITO and AIRO GYN groups

Visualizza Documento …

A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups

Visualizza Documento …